JP2012500194A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500194A5
JP2012500194A5 JP2011522551A JP2011522551A JP2012500194A5 JP 2012500194 A5 JP2012500194 A5 JP 2012500194A5 JP 2011522551 A JP2011522551 A JP 2011522551A JP 2011522551 A JP2011522551 A JP 2011522551A JP 2012500194 A5 JP2012500194 A5 JP 2012500194A5
Authority
JP
Japan
Prior art keywords
polypeptide
protein
peptide
allergen
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522551A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012500194A (ja
JP5705113B2 (ja
Filing date
Publication date
Priority claimed from GB0814986A external-priority patent/GB0814986D0/en
Priority claimed from PCT/GB2008/002781 external-priority patent/WO2009022157A2/en
Priority claimed from GB0815218A external-priority patent/GB0815218D0/en
Priority claimed from GBGB0901927.4A external-priority patent/GB0901927D0/en
Priority claimed from EP09251252.4A external-priority patent/EP2153841B2/en
Priority claimed from GB0912578A external-priority patent/GB0912578D0/en
Application filed filed Critical
Priority claimed from PCT/GB2009/001995 external-priority patent/WO2010018384A1/en
Publication of JP2012500194A publication Critical patent/JP2012500194A/ja
Publication of JP2012500194A5 publication Critical patent/JP2012500194A5/ja
Publication of JP5705113B2 publication Critical patent/JP5705113B2/ja
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522551A 2008-08-15 2009-08-14 Ｉｌ−１０産生の刺激のためのアレルゲン由来のｔ細胞抗原 Expired - Fee Related JP5705113B2 (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
GB0814986A GB0814986D0 (en) 2008-08-15 2008-08-15 Peptide for il10 production
PCT/GB2008/002781 WO2009022157A2 (en) 2007-08-15 2008-08-15 Peptide with improved solubility
GBPCT/GB08/002779 2008-08-15
PCT/GB2008/002779 WO2009022155A2 (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
PCT/GB2008/002778 WO2009022154A2 (en) 2007-08-15 2008-08-15 Peptide with multiple epitopes
GBPCT/GB08/002780 2008-08-15
GBPCT/GB08/002778 2008-08-15
PCT/GB2008/002780 WO2009022156A2 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
GBPCT/GB08/002781 2008-08-15
GB0814986.6 2008-08-15
GB0815218A GB0815218D0 (en) 2008-08-20 2008-08-20 Ragweed peptides for vaccine
GB0815218.3 2008-08-20
GBGB0901927.4A GB0901927D0 (en) 2009-02-05 2009-02-05 Peptide for IL10 production
GB0901927.4 2009-02-05
EP09251252.4 2009-05-01
EP09251252.4A EP2153841B2 (en) 2008-08-15 2009-05-01 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
GB0912578A GB0912578D0 (en) 2009-07-20 2009-07-20 Peptide for IL-10 production
GB0912578.2 2009-07-20
PCT/GB2009/001995 WO2010018384A1 (en) 2008-08-15 2009-08-14 T-cell antigen peptide from allergen for stimulation of il-10 production

Publications (3)

Publication Number Publication Date
JP2012500194A JP2012500194A (ja) 2012-01-05
JP2012500194A5 true JP2012500194A5 (enExample) 2012-10-04
JP5705113B2 JP5705113B2 (ja) 2015-04-22

Family

ID=41112622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011522551A Expired - Fee Related JP5705113B2 (ja) 2008-08-15 2009-08-14 Ｉｌ−１０産生の刺激のためのアレルゲン由来のｔ細胞抗原

Country Status (4)

Country Link
US (2) US8821887B2 (enExample)
EP (1) EP2331124A1 (enExample)
JP (1) JP5705113B2 (enExample)
WO (1) WO2010018384A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103784952B (zh) 2009-02-05 2016-08-17 切尔卡西亚有限公司 用于疫苗的草肽
GB201002559D0 (en) 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
CN103501812A (zh) 2011-04-29 2014-01-08 西莱克塔生物科技公司 用于过敏症治疗的致耐受性合成纳米载体
CN109172819A (zh) 2011-07-29 2019-01-11 西莱克塔生物科技公司 产生体液和细胞毒性t淋巴细胞（ctl）免疫应答的合成纳米载体
GB201209862D0 (en) * 2012-06-01 2012-07-18 Circassia Ltd Cladosporium peptides
DK2914286T3 (da) 2012-10-30 2021-11-08 Aravax Pty Ltd Hidtil ukendte immunterapeutiske molekyler og anvendelser deraf
CA2910584A1 (en) 2013-05-03 2014-11-06 Selecta Biosciences, Inc. Use of immunosuppressants attached to synthetic nanocarriers to enhance levels of cd4+ regulatory t cells
KR20160075532A (ko) 2013-09-25 2016-06-29 아라백스 피티와이 엘티디 신규한 면역치료제 조성물 및 이의 용도
CA2933552A1 (en) * 2013-12-23 2015-07-02 Alk-Abello A/S Peptide combinations and uses thereof in treating dust mite allergy
WO2016037163A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating gene therapy anti-viral transfer vector immune responses
EP3556778A1 (en) * 2015-03-30 2019-10-23 Osaka University Immunizing peptide, method for producing immunizing peptide, pharmaceutical composition for immune disorders containing same, and method for treating immune disorders
EP3592389B1 (en) 2017-03-11 2025-05-07 Cartesian Therapeutics, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
JP7220489B2 (ja) * 2019-10-18 2023-02-10 沛爾生技醫藥股▲分▼有限公司 炎症性疾患および疼痛を治療するためのペプチドを含有する薬剤

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2049921C (en) * 1989-03-17 2004-06-15 Bruce Rogers Allergenic proteins from ragweed and uses therefor
US5776761A (en) 1989-03-17 1998-07-07 Immulogic Pharmaceutical Corporation Nucleic acids encoding allergenic proteins from ragweed
DK0548200T3 (da) * 1990-09-11 1999-10-25 Inst Child Health Research Kloning og sekventering af allergener fra dermatophagoides (husstøvmide)
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
EP0623168B1 (en) 1991-10-16 2009-09-30 Merck Patent GmbH T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US6441157B1 (en) 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
EP0770681A3 (en) 1992-04-09 1997-06-04 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
JPH09501043A (ja) * 1993-04-14 1997-02-04 イミュロジク ファーマスーティカル コーポレイション Ｄｅｒｍａｔｏｐｈａｇｏｉｄｅｓ（室内塵ダニ）由来の主要アレルゲンのｔ細胞エピトープ
WO1995028424A1 (en) 1994-04-14 1995-10-26 Immulogic Pharmaceutical Corporation Pharmaceutical peptide formulations for treatment of dust mite allergy
US5820862A (en) 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US7112333B1 (en) 1994-08-05 2006-09-26 Heska Corporation T cell epitopes of ryegrass pollen allergen
WO1996013589A1 (en) 1994-10-27 1996-05-09 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
JP2002500198A (ja) 1998-01-09 2002-01-08 サーカシア リミテッド 脱感作のための方法及び組成物
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
GB0108752D0 (en) 2001-04-06 2001-05-30 Isis Innovation Peptide epitopes and uses thereof
JP4874522B2 (ja) 2001-12-05 2012-02-15 サーカッシア リミテッド 免疫療法および系
AUPS148202A0 (en) 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
AU2003228133A1 (en) 2002-04-22 2003-11-03 Umc Utrecht Holding B.V. Reduction of unwanted immune reactions
GB0210741D0 (en) 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
FR2841906B1 (fr) 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
GB0308988D0 (en) 2003-04-17 2003-05-28 Univ Singapore Molecule
WO2006075253A2 (en) 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
US20090130130A1 (en) 2005-06-10 2009-05-21 National University Of Singapore Mutant allergen(s)
US20070092532A1 (en) 2005-10-25 2007-04-26 Board Of Trustees Operating Michigan State University Arthritis vaccines and methods
ES2405552T3 (es) 2005-11-29 2013-05-31 Actogenix N.V. Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos
EP1958645A1 (en) 2007-02-13 2008-08-20 Biomay AG Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof
EP2156183B1 (en) 2007-05-09 2013-08-07 Circassia Limited Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
ES2402956T3 (es) 2007-08-15 2013-05-10 Circassia Limited Péptido con formación de dímeros reducida
EP2042193A1 (en) 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
EP2153841B2 (en) * 2008-08-15 2015-11-11 Circassia Limited Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy

Similar Documents

Publication Publication Date Title
JP2012500194A5 (enExample)
CN102227214B (zh) 二聚体形成减少的组合物
Rafferty et al. Peptide therapeutics and the pharmaceutical industry: barriers encountered translating from the laboratory to patients
JP5755398B2 (ja) 伸長されたｇｌｐ−１化合物
ES2402956T3 (es) Péptido con formación de dímeros reducida
ES2532116T3 (es) Péptidos derivados con A-B-C-D y sus usos terapéuticos
US20230073594A1 (en) Lactoferrin compositions and methods for modulation of t cell subtypes and treatment of autoimmune diseases
Windeløv et al. Why is it so difficult to measure glucagon-like peptide-1 in a mouse?
JP5209463B2 (ja) アシル化ｇｌｐ−１化合物
Virtanen et al. Mammalian lipocalin allergens–insights into their enigmatic allergenicity
JP2010536333A5 (enExample)
US8821887B2 (en) T-cell antigen peptide from allergen for stimulation of IL-10 production
US20190070287A1 (en) Tolerance therapeutic for treating polypeptide induced immune activation
US20120231999A1 (en) Peptidic glp-2 agonists
KR20110017874A (ko) 오래 작용하는 ｙ２ 및／또는 ｙ４ 수용체 작용제
US20150141336A1 (en) Pancreatic Peptide Compounds and Use
HRP20120206T4 (hr) Cjepivo koje sadrži amb a 1 peptide za uporabu u lijeäśenju alergije na ambroziju
JP2012516693A5 (enExample)
KR20190017017A (ko) 프로테아제-내성 모노-지질화된 펩타이드
FR2744123A1 (fr) Molecules biologiquement actives plus particulierement peptidiques ayant un effet potentialisateur de l'activite biologique de l'hormone de croissance
US20250388638A1 (en) Compositions and methods for oral delivery
JP2007512812A (ja) 羊膜由来ペプチドおよびその使用
AU2015227499A1 (en) Compositions with reduced dimer formation